Hong Kong, Macau suspend use of Pfizer/BioNTech's coronavirus vaccine over packaging problem

The governments in Hong Kong and Macau have suspended the use of coronavirus vaccine by Pfizer/BioNTech over a packaging problem with a batch of vials. "For the sake of precaution, the current vaccination must be suspended during the period of investigation," the government in Hong Kong said. The vaccine doses were suspended for use after the pharma firm Fosun contacted the government to inform about the defective package.